New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
Med. oral patol. oral cir. bucal (Internet)
; 22(5): e601-e608, sept. 2017. ilus, tab, graf
Artigo
em Inglês
| IBECS
| ID: ibc-166655
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Background:
Thrombotic disorders remain a leading cause of death in the Western World. For decades, vitamin K antagonists used in the prevention of this pathology, such as warfarin or sintrom, were the only oral agents available for long-term anticoagulation, in spite of their disadvantages. Material andMethods:
An electronic database search was carried out on MedLine and The Cochrane Library Plus, without restrictions on the type of study nor dates, in English and Spanish. Abstracts were reviewed, and complete articles if necessary, considering all articles that included recommendations on DOACs and oral surgery.Results:
In recent years, the so-called "new oral anticoagulants" have been introduced in clinical practice to treat those patients whose medical conditions require long-term anticoagulant treatment, replacing traditional oral anticoagulants.Conclusions:
The new oral anticoagulants represent new therapeutic options, with a number of advantages such as poor interaction with food, minor drug interactions, and do not require periodic dose adjustments or routine controls. The purpose of this review is to establish an update on the new oral anticoagulants Dabigatran, Rivarozaban, Apixaban and Edoxaban (AU)RESUMEN
No disponible
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Perda Sanguínea Cirúrgica
/
Procedimentos Cirúrgicos Bucais
/
Anticoagulantes
Tipo de estudo:
Guia de prática clínica
Limite:
Humanos
Idioma:
Inglês
Revista:
Med. oral patol. oral cir. bucal (Internet)
Ano de publicação:
2017
Tipo de documento:
Artigo
Instituição/País de afiliação:
Complutense University of Madrid/Spain